| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/05/2004 | US20040023968 Phthalazinone derivatives |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | CA2493309A1 Site-specific labelling of proteins using cyanine dye reporters |
| 02/04/2004 | CN1473163A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1472209A ²-carboline and sulfo-analogues subsitituted for amino-acid radical, preparing method and application thereof |
| 02/04/2004 | CN1472208A Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/04/2004 | CN1137124C Process for preparing (3as, 6aR)-1.3-dibenzyl-tetrahydro-4H-thiophenebin [3,4-d] imidazolium-2, 4-(1H)-diketone |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003000194A3 Thienopyridine and thienopyrimidine anticancer agents |
| 01/29/2004 | WO2002060906A8 Crystal modification of olanzapine |
| 01/29/2004 | US20040019065 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use |
| 01/29/2004 | US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040018543 Incubation; controlling temperature and pH |
| 01/29/2004 | US20040016370 Coatings, films, circuit board |
| 01/28/2004 | EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors |
| 01/28/2004 | EP1384481A1 Remedies for vesical hyperesthesia |
| 01/28/2004 | EP1384480A1 Remedies for vesical hyperactivity |
| 01/28/2004 | EP1383771A1 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383732A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 01/28/2004 | EP1383463A2 Pharmaceutically active compounds and methods of use |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP0981525B1 (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitriles as intermediates and process for the preparation thereof |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/27/2004 | US6683105 Highly selective butyrylcholinesterase inhibitors such as cymserine or others can prevent or treat cognitive impairments associated with aging or alzheimer's disease |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007504A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | WO2004006933A2 Crystal forms of olanzapine and processes for their preparation |
| 01/22/2004 | WO2004006926A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | WO2003059356A3 Novel anti-infectives |
| 01/22/2004 | US20040014995 Chromene compounds |
| 01/22/2004 | US20040014803 Antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014756 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 01/22/2004 | US20040014755 Rho-kinase inhibitors |
| 01/22/2004 | US20040014740 Compound containing sulfur containing ring; parasiticides |
| 01/22/2004 | US20040014634 Thieno[2,3-d]pyrimidinediones and their use as pharmaceuticals |
| 01/22/2004 | CA2492673A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | CA2492086A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP1381608A1 Cyclohexylphenyl vasopressin agonists |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP1381370A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/20/2004 | US6680389 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions |
| 01/15/2004 | WO2004005297A1 Pyrrole derivative and process for producing the same |
| 01/15/2004 | WO2004004734A1 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder |
| 01/15/2004 | US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009978 Bicyclic or tricyclic fused pyrimidine derivatives or salts thereof which possess phosphatidylinositol 3 kinase (PI3K) inhibiting and antitumor activity |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009965 Treating hyperproliferative disorders |
| 01/15/2004 | US20040009890 Structure-based design of a drug that can act as an inhibitor of at least two different biological entities using computer modeling; useful for designing HIV protease inhibitors and antineoplastic agents and where drug resistance may exist. |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380299A1 Remedies for vesical stimulation in association with prostatauxe |
| 01/14/2004 | EP1019385B1 Aminoaryl oxazolidinone n-oxides |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468230A Chemical compounds |
| 01/14/2004 | CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury |
| 01/08/2004 | US20040006062 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | CN1466588A Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
| 01/07/2004 | CN1466583A Design and synthesis of advanced NLO materials for electro-optic applications |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | CA2247063C Treatment of macular edema |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372640A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 01/02/2004 | EP1372639A2 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
| 01/02/2004 | EP1372630A2 Agent for the treatment of overactive bladder |
| 01/01/2004 | US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 01/01/2004 | US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
| 12/31/2003 | WO2004000847A1 A process for the preparation of olanzapine and an intermediate therefor |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |